Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

55.75
Delayed Data
As of Feb 12
 +1.67 / +3.09%
Today’s Change
53.78
Today|||52-Week Range
72.31
-15.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues4.8B4.6B4.9B4.8B
 
 
 
 
 
Cost of Goods Sold1.8B1.7B1.7B1.7B
 
 
 
 
 
Depreciation And Amortization342.8M310.6M318.3M314.9M
 
 
 
 
 
 
Operating ExpensesGross Income2.7B2.6B2.8B2.8B
 
 
 
 
 
General Expenses1.6B1.4B1.5B1.5B
 
 
 
 
 
Research And Development352.1M307.8M380.4M360.8M
 
 
 
 
 
Total Operating Expenses3.7B3.4B3.6B3.5B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.1B1.2B1.3B1.3B
 
 
 
 
 
Extraordinary Credit132.8M32.4M6.9M125.9M
 
 
 
 
 
Extraordinary Charge-240.6M-632.3M-667.1M-1.0B
 
 
 
 
 
Interest Expense On Debt156.1M53.8M33.5M--
 
 
 
 
Equity In Earnings7.4M-8.3M5.9M-4.0M
 
 
 
 
 
Other Expenses-26.0M-2.8M8.9M-115.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income810.1M516.4M611.9M312.9M
 
 
 
 
 
Income Taxes-172.8M-96.4M-86.7M-192.9M
 
 
 
 
 
Minority Interest-6.5M-1.9M---13.0M
 
 
 
 
Net Income638.2M413.5M531.1M103.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS854.0M851.0M849.0M851.0M
 
 
 
 
 
Shares To Calculate EPS Diluted861.0M859.0M859.0M862.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.74$0.48$0.63$0.12
 
 
 
 
 
EPS Diluted$0.74$0.48$0.62$0.12